1153 related articles for article (PubMed ID: 34341185)
21. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
[TBL] [Abstract][Full Text] [Related]
22. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
Huang C; Li K; Huang R; Zhu J; Yang J
Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
[TBL] [Abstract][Full Text] [Related]
23. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.
Yao J; Yang Z; Yang J; Wang ZG; Zhang ZY
Aging (Albany NY); 2021 May; 13(10):13726-13738. PubMed ID: 34023817
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA SBF2-AS1 promotes colorectal cancer proliferation and invasion by inhibiting miR-619-5p activity and facilitating HDAC3 expression.
Chen G; Gu Y; Han P; Li Z; Zhao JL; Gao MZ
J Cell Physiol; 2019 Aug; 234(10):18688-18696. PubMed ID: 30912164
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression.
Zhu H; Zhang H; Pei Y; Liao Z; Liu F; Su C; Liu Y; Dong R; Song J; Zhang X; Fan Y; Liang H; Zhang B; Chen X
J Exp Clin Cancer Res; 2021 Feb; 40(1):57. PubMed ID: 33541391
[TBL] [Abstract][Full Text] [Related]
28. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
[TBL] [Abstract][Full Text] [Related]
30. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
[TBL] [Abstract][Full Text] [Related]
31. Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development.
Yin Z; Zhou Y; Ma T; Chen S; Shi N; Zou Y; Hou B; Zhang C
J Cell Mol Med; 2020 May; 24(9):5028-5038. PubMed ID: 32301277
[TBL] [Abstract][Full Text] [Related]
32. Long Noncoding RNA
Gong X; Zhu Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
[No Abstract] [Full Text] [Related]
33. DANCR contributed to hepatocellular carcinoma malignancy via sponging miR-216a-5p and modulating KLF12.
Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
J Cell Physiol; 2019 Jun; 234(6):9408-9416. PubMed ID: 30430564
[TBL] [Abstract][Full Text] [Related]
34. lncRNA RBM5-AS1 promotes cell proliferation and invasion by epigenetically silencing miR-132/212 in hepatocellular carcinoma cells.
Mu JY; Tian JX; Chen YJ
Cell Biol Int; 2021 Nov; 45(11):2201-2210. PubMed ID: 34019714
[TBL] [Abstract][Full Text] [Related]
35. Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis.
Liu X; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X; Meng Y
Cancer Gene Ther; 2021 May; 28(5):486-501. PubMed ID: 33277615
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
37. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis.
Huang Y; Xiang B; Liu Y; Wang Y; Kan H
Cancer Lett; 2018 Nov; 437():56-66. PubMed ID: 30165194
[TBL] [Abstract][Full Text] [Related]
38. LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma.
Zhang N; Shen H; Huang S; Wang F; Liu H; Xie F; Jiang L; Chen X
Eur J Histochem; 2021 Nov; 65(4):. PubMed ID: 34783233
[TBL] [Abstract][Full Text] [Related]
39. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
Teng F; Zhang JX; Chang QM; Wu XB; Tang WG; Wang JF; Feng JF; Zhang ZP; Hu ZQ
J Exp Clin Cancer Res; 2020 Nov; 39(1):235. PubMed ID: 33168027
[TBL] [Abstract][Full Text] [Related]
40. LncRNA TP73-AS1/miR-539/MMP-8 axis modulates M2 macrophage polarization in hepatocellular carcinoma via TGF-β1 signaling.
Chen J; Huang ZB; Liao CJ; Hu XW; Li SL; Qi M; Fan XG; Huang Y
Cell Signal; 2020 Nov; 75():109738. PubMed ID: 32818670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
